Participant Protection in Phase 1 Pediatric Cancer Trials

JAMA Pediatrics
January 2019, Vol 173, No. 1, Pages 3-112
http://archpedi.jamanetwork.com/issue.aspx

Participant Protection in Phase 1 Pediatric Cancer Trials
Jonathan Kimmelman, PhD; Marcin Waligora, PhD; Holly Fernandez Lynch, JD, MBe
JAMA Pediatr. 2019;173(1):8-9. doi:10.1001/jamapediatrics.2018.3629
This Viewpoint describes changes in the regulatory environment for phase 1 research involving children and discusses improvements to patient protection.